Patents by Inventor Stefan Soderman

Stefan Soderman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LSD derivatives, synthesis and method for treatment of diseases and disorders
    Patent number: 12331051
    Abstract: LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of Formula I: including pharmaceutically acceptable salts, hydrates, solvates, tautomers, enantiomers, diastereomers, racemates, polymorphs or combinations thereof; wherein: R1 to R14 are each independently selected from H, or a substituted or unsubstituted hydrocarbon group and X is selected from a halo group.
    Type: Grant
    Filed: June 26, 2023
    Date of Patent: June 17, 2025
    Assignee: BETTERLIFE PHARMA INC.
    Inventors: Hooshmand Sheshbaradaran, Scott Rudge, Abdi Ghaffari, Stefan Soderman, Petar Duspara
  • LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS
    Publication number: 20230357243
    Abstract: LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of Formula I: including pharmaceutically acceptable salts, hydrates, solvates, tautomers, enantiomers, diastereomers, racemates, polymorphs or combinations thereof; wherein: R1 to R14 are each independently selected from H, or a substituted or unsubstituted hydrocarbon group and X is selected from a halo group.
    Type: Application
    Filed: June 26, 2023
    Publication date: November 9, 2023
    Inventors: Hooshmand Sheshbaradaran, Scott Rudge, Abdi Ghaffari, Stefan Soderman, Peter Duspara
  • LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS
    Publication number: 20230219955
    Abstract: LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of Formula I: including pharmaceutically acceptable salts, hydrates, solvates, tautomers, enantiomers, diastereomers, racemates, polymorphs or combinations thereof; wherein: R1 to R14 are each independently selected from H, or a substituted or unsubstituted hydrocarbon group and X is selected from a halo group.
    Type: Application
    Filed: September 20, 2022
    Publication date: July 13, 2023
    Inventors: Hooshmand Sheshbaradaran, Scott Rudge, Abdi Ghaffari, Stefan Soderman, Petar Duspara